Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background High-level aminoglycoside resistance (HLAR) that precludes bactericidal synergism with penicillins or glycopeptides and nephrotoxicity related to aminoglycoside treatment are major problems in treating Enterococcus faecalis endocarditis. Objective To evaluate the efficacy and safety of ampicillin plus ceftriaxone for treating endocarditis due to E. faecalis with and without HLAR. Design Observational, open-label, nonrandomized, multicenter clinical trial. Setting 13 centers in Spain. Patients 21 patients with HLAR E. faecalis endocarditis and 22 patients with non-HLAR E. faecalis endocarditis. All were at risk for nephrotoxicity related to aminoglycoside use. Intervention 6-week course of intravenous ampicillin, 2 g every 4 hours, plus intravenous ceftriaxone, 2 g every 12 hours. Measurements Clinical and microbiological outcomes. Results The clinical cure rate at 3 months was 67.4% (29 of 43 patients) among all episodes. During treatment, 28.6% of patients with HLAR E. faecalis endocarditis and 18.2% of patients with non-HLAR E. faecalis endocarditis died of infection-related causes. The rate of clinical and microbiological cure in patients who completed the protocol was 100% in the HLAR E. faecalis endocarditis group. No episodes of breakthrough bacteremia occurred, although there were 2 relapses in the non-HLAR E. faecalis endocarditis group. Treatment was withdrawn in 1 case because of fever and skin rash. Limitations The study had a small sample and was observ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the study by Gavaldà et al,190 approximately half of the patients had IE caused by highlevel aminoglycoside-resistant strains of E faecalis.”
In the citing paper
“A smaller study by this group compared ceftriaxone-ampicillin therapy of aminoglycoside-susceptible with high-level aminoglycoside-resistant E faecalis IE. 190”
In the citing paper
“Third, none of the patients in either study developed nephrotoxicity with ampicillin-ceftriaxone therapy, whereas 20 of 87 (23%) ampicillin-gentamicin-treated patients developed nephrotoxicity (P<0.001).”
In the citing paper
“First, these are the largest series of E faecalis IE reported to date, 43 patients in 1 study 190 and 272 in the other study.191”
In the citing paper
“Second, high-level aminoglycoside-resistant E faecalis IE treated with ampicillin-ceftriaxone therapy was present in 50% of the patients in the smaller study and 33% of patients in the larger study.”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Identification of Enterococcus species isolated from human infections by a conventional test scheme
Facklam, R. R., & Collins, M. D. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.4.731-734.1989 · Cited by 791 · cited 2×
“faecalis strains by using the API 20 STREP system (bioMérieux, La Balme-les-Grottes, France) and later confirmed them according to the criteria recommended by Facklam and Collins (15) in a reference laboratory.”
MethodEnterococcal Endocarditis in Sweden, 1995–1999: Can Shorter Therapy with Aminoglycosides Be Used?
Olaison, L., Schadewitz, K., & Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis (2002) · Clinical Infectious Diseases · doi:10.1086/338233 · Cited by 166 · cited 1×
“6%] patients) was similar to that reported in 2 recent studies: 3 of 93 (3%) patients in Olaison and Schadewitz’s study (21) and 3.”
ResultBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165563 · Cited by 159
Jones, R. N., Sader, H. S., Erwin, M. E., & Anderson, S. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(94)00147-o · Cited by 154 · cited 1×
“High-level aminoglycoside resistance precludes bactericidal synergism with penicillins or glycopeptides (3, 5, 6, 9, 10).”
BackgroundPrevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.
Rc, M., Wennersten, C. B., Medrek, T. F., & Weinberg, A. N. (1970) · PubMed · Cited by 138
Gavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.639 · Cited by 134 · cited 3×
“In previous studies, our group demonstrated the efficacy of this combination for treating experimental endocarditis due to these strains (11, 12).”
BackgroundMethodSelf-citationClinical and bacteriological characteristics of infective endocarditis in the elderly.
Selton-Suty, C., Hoen, B., Grentzinger, A., Houplon, P., Maignan, M., Juillière, Y., Danchin, N., Canton, P., & Cherrier, F. (1997) · Heart · doi:10.1136/hrt.77.3.260 · Cited by 118
Calderwood, S. A., Wennersten, C. B., Moellering, R. C., Kunz, L. J., & Krogstad, D. J. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.401 · Cited by 94 · cited 1×
“High-level aminoglycoside resistance precludes bactericidal synergism with penicillins or glycopeptides (3, 5, 6, 9, 10).”
Background
Research works printed but not linked: 3
- Moellering RC, 1970, Antimicrobial Agents Chemother (Bethesda), 10, 335
- Cirak MY, 1998, Acta Microbiol Pol, 47, 267
- Olesen HV, 2002, Ugeskr Laeger, 164, 2386
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“It is also safer, without any nephrotoxicity.(183) – 185 In addition, this is the combination of choice for treating HLAR E.”
Self-citationMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
“The combination of ampicillin and high-dose ceftriaxone was used successfully in a nonrandomized study of enterococcal endocarditis for patients in which use of an aminoglycoside was precluded because of either antimicrobial resistance or nephrotoxicity [167].”
MethodBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“A smaller study by this group compared ceftriaxone-ampicillin therapy of aminoglycoside-susceptible with high-level aminoglycoside-resistant E faecalis IE.(190) Both of these studies had significant limitations: They were observational, largely retrospective, and nonrandomized; the regimens were not standardized among…”
ResultGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Self-citation2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citation
Metadata
- Authors
- Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., Bou, G., Aguado, J. M., Navas, E., Romeu, J., Marco, F., Torres, C., Tornos, P., Planes, A., Falcó, V., Almirante, B., & Pahissa, A.
- Affiliations
- Universidad de La Rioja (ES)
- From the Hospital Universitari Vall d'Hebron, Institut d'Investigacions Biomediques August Pi i Sunyer, Hospital de Bellvitge, Mutua de Terrassa, and Hospital Germans Tries i Pujol, Barcelona, Spain; Hospital Gregorio Marañón, Hospital Universitario de La Princesa, Hospital Doce de Octubre, and Hospital Ramón y Cajal, Madrid, Spain; Hospital de Cruces, Barakaldo, Spain; Hospital Virgen del Rocío, Seville, Spain; Hospital Reina Sofía, Córdoba, Spain;
- Corresponding author
- Gavaldà, Joan
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-04-17
- Volume
- 146
- Issue
- 8
- Pages
- 574-579
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2161863262
- Semantic Scholar
- eee52057b632a782627ab2573078e0b7b670b997
- Cited by
- 202
- References
- 20
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 12 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 6 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 16 · 2014: 10 · 2013: 18 · 2012: 11
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- Enterococcus faecalis, infective endocarditis, high-level aminoglycoside resistance, ampicillin, ceftriaxone, combination antibiotic therapy, nephrotoxicity, clinical cure rate, microbiological cure, relapse, treatment safety
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aminoglycosides, Ampicillin, Anti-Bacterial Agents, Ceftriaxone, Child, Child, Preschool, Drug Resistance, Microbial, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Humans, Infant, Male, Middle Aged, Enterococcus faecalis, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone. https://app.cochat.ai/papers/10.7326/0003-4819-146-8-200704170-00008
- The paper
- Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., Bou, G., Aguado, J. M., Navas, E., Romeu, J., Marco, F., Torres, C., Tornos, P., Planes, A., Falcó, V., . . . Pahissa, A. (2007). Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-146-8-200704170-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.